195 related articles for article (PubMed ID: 27319402)
1. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Singh S; Houng AK; Wang D; Reed GL
J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
[TBL] [Abstract][Full Text] [Related]
2. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
Reed GL; Houng AK; Wang D
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
[TBL] [Abstract][Full Text] [Related]
3. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
5. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
9. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
[TBL] [Abstract][Full Text] [Related]
10. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.
Kraft P; Göb E; Schuhmann MK; Göbel K; Deppermann C; Thielmann I; Herrmann AM; Lorenz K; Brede M; Stoll G; Meuth SG; Nieswandt B; Pfeilschifter W; Kleinschnitz C
Stroke; 2013 Nov; 44(11):3202-10. PubMed ID: 24029635
[TBL] [Abstract][Full Text] [Related]
11. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.
Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H
Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804
[TBL] [Abstract][Full Text] [Related]
12. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
Thériault P; Le Béhot A; ElAli A; Rivest S
Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
14. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
[TBL] [Abstract][Full Text] [Related]
15. Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion.
Wong CH; Bozinovski S; Hertzog PJ; Hickey MJ; Crack PJ
J Neurochem; 2008 Oct; 107(1):241-52. PubMed ID: 18691391
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Kelly PJ; Morrow JD; Ning M; Koroshetz W; Lo EH; Terry E; Milne GL; Hubbard J; Lee H; Stevenson E; Lederer M; Furie KL
Stroke; 2008 Jan; 39(1):100-4. PubMed ID: 18063832
[TBL] [Abstract][Full Text] [Related]
18. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.
Zechariah A; ElAli A; Hermann DM
Stroke; 2010 May; 41(5):1008-12. PubMed ID: 20360548
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
[TBL] [Abstract][Full Text] [Related]
20. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.
Langhauser F; Göb E; Kraft P; Geis C; Schmitt J; Brede M; Göbel K; Helluy X; Pham M; Bendszus M; Jakob P; Stoll G; Meuth SG; Nieswandt B; McCrae KR; Kleinschnitz C
Blood; 2012 Nov; 120(19):4082-92. PubMed ID: 22936662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
